2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2005040365v1 16/11/3357    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Merx, M. W. Articles by Jahnen-Dechent, W. Search for Related Content PubMed PubMed Citation Articles by Merx, M. W. Articles by Jahnen-Dechent, W.

Myocardial Stiffness, Cardiac Remodeling, and Diastolic Dysfunction in Calcification-Prone Fetuin-A–Deficient Mice

Marc W. Merx^*, Cora Schäfer, Ralf Westenfeld, Vincent Brandenburg^,, Sylvia Hidajat^*, Christian Weber^*,, Markus Ketteler and Willi Jahnen-Dechent

^* Medical Clinic I, IZKF BIOMAT, Medical Clinic II, and Department of Cardiovascular Molecular Biology, RWTH University Hospital, Aachen, Germany

Address correspondence to: Dr. Marc W. Merx, Medizinische Klinik I, Universitätsklinikum RWTH Aachen, Pauwelsstrasse 30, Aachen, Germany D-52057. Phone: +49-241-8089300; Fax: +49-241-8082545; E-mail: mmerx{at}ukaachen.de

Received for publication April 6, 2005. Accepted for publication August 13, 2005.

Accelerated atherosclerosis in dialysis patients is characterized by severe vascular calcification, and the magnitude of vascular calcification is associated with increased cardiovascular mortality. Calcification-dependent arterial stiffness is considered to be a major determinant of cardiac failure in uremia. Fetuin-A/₂-Heremans-Schmid glycoprotein is an abundant serum protein with powerful calcification inhibitory properties. Fetuin-A deficiency was recently linked to cardiovascular mortality in dialysis patients. Fetuin-A knockout (fetuin-KO) mice spontaneously develop widespread soft tissue calcification, including significant myocardial calcification, whereas larger arteries are spared. Therefore, this investigation offers the unique opportunity to study the functional role of isolated myocardial calcification independent of arterial stiffness by assessing the hemodynamics of fetuin-KO mice. Cardiac output in fetuin-KO mice was lower than in wild-type mice (fetuin-KO 1.81 ± 0.18 versus WT 2.45 ± 0.29 ml/min per g; P < 0.005), and fetuin-KO mice were refractory to dobutamine stimulation. Left ventricular relaxation was significantly impaired in fetuin-KO hearts with the relaxation index reduced by 23% (P < 0.005). After ischemia, fetuin-KO hearts displayed a continuous decline in left ventricular developed pressure after the initial phase of reperfusion, resulting in 77 ± 15% of preischemic left ventricular developed pressure (P < 0.05 versus wild-type). In fetuin-KO mice, dystrophic cardiac calcification, with myocardial calcium contents increased 60-fold, was associated with profound induction of profibrotic TGF- and downstream collagen and fibronectin mRNA synthesis. In conclusion, independent of arterial stiffness, calcification-associated "myocardial stiffness" characterized by cardiac fibrosis, diastolic dysfunction, impaired tolerance to ischemia, and catecholamine resistance thus may constitute an underestimated cardiovascular risk factor that contributes to cardiac failure in calcification-prone states.

This article has been cited by other articles:

				U. D. Akavia and D. Benayahu Meta-analysis and profiling of cardiac expression modules Physiol Genomics, November 12, 2008; 35(3): 305 - 315. [Abstract] [Full Text] [PDF]

				R. C. Shroff, V. Shah, M. P. Hiorns, M. Schoppet, L. C. Hofbauer, G. Hawa, L. J. Schurgers, A. Singhal, I. Merryweather, P. Brogan, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3263 - 3271. [Abstract] [Full Text] [PDF]

				P. Lim, J.-P. Collet, S. Moutereau, N. Guigui, L. Mitchell-Heggs, S. Loric, M. Bernard, S. Benhamed, G. Montalescot, J.-L. D. Rande, et al. Fetuin-A Is an Independent Predictor of Death after ST-Elevation Myocardial Infarction Clin. Chem., October 1, 2007; 53(10): 1835 - 1840. [Abstract] [Full Text] [PDF]

				R. Westenfeld, C. Schafer, R. Smeets, V. M. Brandenburg, J. Floege, M. Ketteler, and W. Jahnen-Dechent Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1537 - 1546. [Abstract] [Full Text] [PDF]

				J.-S. Shao, J. Cai, and D. A. Towler Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430. [Abstract] [Full Text] [PDF]

				M. Ketteler, G. Schlieper, and J. Floege Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon Hypertension, June 1, 2006; 47(6): 1027 - 1034. [Full Text] [PDF]

				C. M. Shanahan Vascular calcification--a matter of damage limitation? Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1166 - 1169. [Full Text] [PDF]

				M. Woltje, B. Tschoke, V. von Bulow, R. Westenfeld, B. Denecke, S. Graber, and W. Jahnen-Dechent CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression. J. Mol. Endocrinol., April 1, 2006; 36(2): 261 - 277. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673